Topics

Gliomas | Treatment | Targeted therapy

Home > Publications > Topics > Gliomas > Treatment > Targeted therapy

□ OVERVIEW

□ ⁶⁴Cu-ATSM

□ ANLOTINIB

□ BEVACIZUMAB

□ CRELOSIDENIB/LY3410738

□ DABRAFENIB

□ DORDAVIPRONE (ONC201)

□ EGFR INHIBITORS

□ ERDAFITINIB

□ EVOLOCUMAB

□ IDH INHIBITORS

□ INFIGRATINIB

□ IVOSIDENIB

□ LAROTRECTINIB

□ LB100

□ NIVOLUMAB

□ PEPTIDE-BASED THERAPY

□ RADIONUCLIDE THERAPY

□ BRAF/MEK INHIBITORS

□ PAMIPARIB

□ PARP INHIBITORS

□ PRITUMUMAB

□ SAFUSIDENIB

□ STEM CELL THERAPY

□ TOVORAFENIB

□ TRAMETINIB

□ ULIXERTINIB

□ VORASIDENIB